3 Dihexa Risks Nobody Talks About — Seizures, Cancer Pathway, No Human Data

[00:00:00]Three caution flags on Dihexa that most content skips over. First, zero human clinical trials. That alone should force humility on every claim made about this compound. Second, seizure risk. If Dihexa is strongly pushing synaptogenesis, you have to ask, what if the brain builds the wrong connections?

[00:00:19]What if rapid plasticity lowers the seizure threshold in vulnerable people?

[00:00:24]We don't have human data to answer that cleanly. That makes it a real theoretical concern, not a dismissible one. Third, the HGF/c-Met pathway is involved in growth signaling outside the brain, and c-Met is implicated in certain cancers. The concern isn't paranoia. It comes directly from the biology of the pathway. A compound this potent with this many open questions is not one to treat casually. If you want the full breakdown, link is in the description.